RSNA 2014 

Abstract Archives of the RSNA, 2014


SSM23

Radiation Oncology (Radiation Biology)

Scientific Papers — Radiation Oncology,

Presented on December 3, 2014

Participants

Martin Colman MD, Moderator: Nothing to Disclose
John Christopher Grecula MD, Moderator: Research Grant, Teva Pharmaceutical Industries Ltd Research Grant, Soligenix, Inc Stockholder, Pfizer Inc Stockholder, F. Hoffman-La Roche Ltd Stockholder, WebMD Health Corp Stockholder, Merck & Co, Inc Stockholder, Amgen Inc Stockholder, AstraZeneca PLC Stockholder, Baxter International Inc Stockholder, Bristol-Myers Squibb Company Stockholder, EntreMed, Inc Stockholder, Express Scripts Holding Company Stockholder, General Electric Company Stockholder, Eli Lilly and Company Stockholder, Medtronics

Sub-Events

SSM23-01     Ultrasensitive Detection and Personalized Profiling of Circulating Tumor DNA in Patients with Pancreatic Adenocarcinoma
Evan Osmundson MD, PhD | Aaron Newman PhD | Daniel Klass PhD | Scott Bratman MD, PhD | Li Zhou PhD | Jonathan Pai | Teri Longacre MD | Ash Alizadeh MD, PhD | Albert Koong MD, PhD | Maximilian Diehn MD, PhD

SSM23-02     Nanoparticle Imaging and Treatment of Micrometastasis, Using Targeted Anti-CD47 siRNA Nanoparticle, via Radiotherapy
Satoshi Harada MD | Shigeru Ehara MD | Takahiro Satoh DSc | Masashi Koka RT, PhD | Koichiro Sera

SSM23-03     In Vivo Synergy of Radiation and Antibody-Dependent Cell-Mediated Cytotoxicity
Zachary Morris MD, PhD | David Francis | Paul Harari MD | Paul Sondel | Monica Gressett | Emma Strode | Alexander Rakhmilevich | Emily Guy | Jacquelyn Hank

SSM23-04     Dynamic Perfusion CT for the Evaluation of Perfusion Changes Following Magnetic Hyperthermia Therapy in the Liver VX2 Model
Eleni Liapi MD | Robert Ivkov | Sahar Mirpour MD | Anilchandra Attaluri PhD | Jorge Guzman RT | Laurie Pipitone | Juls Blevins

SSM23-05     The Value of Virtual Non-contrast with Spectral CT in Clear Cell Renal Carcinoma of Triple-phase
Jinyan Wei | Junlin Zhou

SSM23-06     Serum Apolipoprotein C-II/Matrix Metalloproteinase-1 Level as Predictive Biomarker of Outcomes in Patients with Locally Advanced Cervical Cancer after Chemoradiotherapy
Yoko Harima MD, PhD | Koshi Ikeda MD, PhD | Keita Utsunomiya MD, PhD | Atsushi Komemushi MD, PhD | Toshiko Shiga | Noboru Tanigawa MD

Cite This Abstract

Colman, M, Grecula, J, Radiation Oncology (Radiation Biology).  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14045192.html